Sapna Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2011.
2011 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Sapna Pharmaceuticals Private Limited

Sapna Pharmaceuticals Private Limited, a active private limited company, was established on 28 March 2011 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KA2011PTC057887. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 24 professional, Its leadership includes Susheela Kothari (Director), Mamta Ramesh Kothari (Director), Ramesh Kumar Kothari (Director). Past directors included Gajraj Kothari, Dinesh Kothari, Susheela Kothari. It holds ₹13.00 Cr open charges and ₹11.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.269/2, Ground Floor Kothari Business Chambers, Mysore Road, Bangalore, Karnataka, 560026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KA2011PTC057887

  • Registration Number

    057887

  • Incorporation Date

    28 March 2011

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 14 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 13.00 Cr
  • Satisfied Charges ₹ 11.50 Cr
  • Revenue Growth **** -6.06%
  • Profit Growth **** 22.50%
  • Ebitda **** 36.34%
  • Net Worth 2.54%
  • Total Assets **** 9.58%
Company report

Sapna Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sapna Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sapna Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Susheela Kothari Director 20 Mar 2023 Current
Mamta Ramesh Kothari Director 12 Feb 2025 Current
Ramesh Kumar Kothari Director 12 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Dec 2014 Past
Pramod Abcsdd Director 02 Jul 2022 Past
Pramod Abcsdd Director 14 Feb 2025 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 20 Mar 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sapna Pharmaceuticals.

Sapna Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.06% decrease. The company also saw a substantial improvement in profitability, with a 22.5% increase in profit. The company's net worth moved up by a moderate rise of 2.54%.

Sapna Pharmaceuticals revenue growth over time
Sapna Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.06%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.66%
*******
*******
*******
*******
Total Assets
*******
 9.58%
*******
*******
*******
*******
Profit or Loss
*******
 22.50%
*******
*******
*******
*******
Net Worth
*******
 2.54%
*******
*******
*******
*******
EBITDA
*******
 36.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sapna Pharmaceuticals?

Unlock access to Sapna Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹130,000,000.00

Satisfied Charges

₹115,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 10.00 Cr
  • Development Credit Bank Limited : 3.00 Cr
Latest Charge Details
Date Lender Amount Status
20 Oct 2022 Hdfc Bank Limited ₹10.00 Cr Open
29 Jul 2011 Development Credit Bank Limited ₹3.00 Cr Open
23 Mar 2015 Yes Bank Limited ₹6.50 Cr Satisfied
09 Feb 2013 Ing Vysya Bank Limited ₹5.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sapna Pharmaceuticals?

Sapna Pharmaceuticals has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sapna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapna Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sapna Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Mamta Ramesh Kothari was appointed as a Director was appointed as a Director on 12 Feb 2025 & has been associated with this company since 1 year . was documented.

  • Director Appointment

    Ramesh Kumar Kothari was appointed as a Director was appointed as a Director on 12 Feb 2025 & has been associated with this company since 1 year . was recorded as a recent event.

  • Annual General Meeting

    Progress on Sapna Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Sapna Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.

  • Director Appointment

    Progress on Susheela Kothari was appointed as a Director was appointed as a Director on 20 Mar 2023 & has been associated with this company since 2 years 10 months . was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100620400 was registered on 20 Oct 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sapna Pharmaceuticals Private Limited?

The CIN of Sapna Pharmaceuticals Private Limited is U24230KA2011PTC057887.

Where is Sapna Pharmaceuticals Private Limited headquartered?

Sapna Pharmaceuticals Private Limited is headquartered at No.269/2, Ground Floor Kothari Business Chambers, Mysore Road, Bangalore, Karnataka, 560026.

When was Sapna Pharmaceuticals Private Limited incorporated?

Sapna Pharmaceuticals Private Limited was incorporated on 28 March 2011.

Who are the current directors of Sapna Pharmaceuticals Private Limited?

The current directors of Sapna Pharmaceuticals Private Limited are

What is the primary industry of Sapna Pharmaceuticals Private Limited?

The primary industry of Sapna Pharmaceuticals Private Limited is Trade.

Is Sapna Pharmaceuticals Private Limited a listed company?

Sapna Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sapna Pharmaceuticals Private Limited?

The authorized capital of Sapna Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Sapna Pharmaceuticals Private Limited?

The compliance status of Sapna Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available